BAL0891 - SillaJen
Population Pharmacokinetic Modeling and Exposure–Safety Analysis of Neutropenia Incidence Using Data from a BAL0891 Dose-Escalation Trial (EORTC-NCI-AACR 2026) - Sep 11, 2026 - Abstract #247; PB-142; Pres time: Nov 19, 2026; Location: Exhibition Hall; "Abstract will be available as of 4 November (with consent of the author)" 
Clinical • PK/PD data • Oncology
https://cm.eortc.org/cmPortal/Searchable/ena2026/config/Normal#!abstractdetails/0000997350
 
Seunghoon Han
 
Sep 11, 2026
 
Prev Next